Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny

4 3 月, 2026

One Min Read

8 Views

原文: https://finance.yahoo.com/news/canaccord-lowers-hims-hers-health-073036108.html

Last Update: 4 3 月, 2026

Written By

Other Articles

Previous

Bitdeer Technologies Group (BTDR) Revenue Beats Estimates Despite EBITDA Shortfall

Next

Immunovant, Inc. (IMVT) Analysts Raise Price Targets Following Q3 Earnings Update

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept